Search results
Editorial: Restoring our ubiquitination machinery to overcome resistance to cancer therapy
Medical Xpress· 4 days agoA new editorial paper was published in Oncoscience on May 6, 2024, titled, "Restoring our...
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
FierceBiotech· 10 hours agoMagrolimab showed worse performances compared with placebo across multiple efficacy and safety metrics in their respective combinations with chemotherapy, data from the ENHANCE trial have shown ...
Newer Therapies Target Different Melasma Components
Medscape· 3 days agoThe pathogenesis of melasma is complex, with genetic, hormonal, and other components that may play a role when choosing treatments, Nada Elbuluk, MD,...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 14 hours agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
Drug delivery innovations push forth women’s health
Pharmaceutical Technology via Yahoo Finance· 2 days agoA 2023 review by Karen Al-Litani et al explored the industry landscape. In it, the authors explain that “key formulation challenges include the selection...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 3 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Self-management recommended for people with inflammatory arthritis
Medical Xpress· 10 hours agoEULAR—The European Alliance of Associations for Rheumatology—recommends patient self-management for...
MacTel2 Treatment: With Easier Ways to Adapt to Vision Loss
Verywell Health via Yahoo News· 4 days agoSome clinical trials involve gaining access to potential therapies that may be helpful in improving...
‘Load Up,’ Says Goldman Sachs About These 2 Strong Buy Stocks
TipRanks via Yahoo Finance· 4 days agoStock picking is going to get a bit more difficult in the near term, if the word coming out of...
Madrigal Pharmaceuticals senior VP sells $570,000 in stock By Investing.com
Investing.com· 2 hours agoRecent filings with the Securities and Exchange Commission reveal that Robert E. Waltermire, Senior...
